| Telomere dysfunction: a potential cancer predisposition factor X Wu, CI Amos, Y Zhu, H Zhao, BH Grossman, JW Shay, S Luo, WK Hong, ... Journal of the national cancer institute 95 (16), 1211-1218, 2003 | 574 | 2003 |
| A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer H Zhao, J Shen, L Medico, D Wang, CB Ambrosone, S Liu PloS one 5 (10), e13735, 2010 | 476 | 2010 |
| A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis J Shen, CB Ambrosone, RA DiCioccio, K Odunsi, SB Lele, H Zhao Carcinogenesis 29 (10), 1963-1966, 2008 | 423 | 2008 |
| p53 genotypes and haplotypes associated with lung cancer susceptibility and ethnicity X Wu, H Zhao, CI Amos, S Shete, N Makan, WK Hong, FF Kadlubar, ... Journal of the National Cancer Institute 94 (9), 681-690, 2002 | 344 | 2002 |
| Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma Y Horikawa, CG Wood, H Yang, H Zhao, Y Ye, J Gu, J Lin, T Habuchi, ... Clinical cancer research 14 (23), 7956-7962, 2008 | 293 | 2008 |
| XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity X Wu, H Zhao, Q Wei, CI Amos, K Zhang, Z Guo, Y Qiao, WK Hong, ... Carcinogenesis 24 (3), 505-509, 2003 | 222 | 2003 |
| Genetic susceptibility to tobacco-related cancer X Wu, H Zhao, R Suk, DC Christiani Oncogene 23 (38), 6500-6523, 2004 | 202 | 2004 |
| Mitochondrial copy number and risk of breast cancer: a pilot study J Shen, M Platek, A Mahasneh, CB Ambrosone, H Zhao Mitochondrion 10 (1), 62-68, 2010 | 175 | 2010 |
| Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk H Zhao, HB Grossman, MR Spitz, SP Lerner, K Zhang, X Wu The Journal of urology 169 (2), 714-717, 2003 | 166 | 2003 |
| Dietary isothiocyanates, GSTM1, GSTT1, NAT2 polymorphisms and bladder cancer risk H Zhao, J Lin, HB Grossman, LM Hernandez, CP Dinney, X Wu International Journal of Cancer 120 (10), 2208-2213, 2007 | 152 | 2007 |
| Cancer risk associated with chronic diseases and disease markers: prospective cohort study H Tu, CP Wen, SP Tsai, WH Chow, C Wen, Y Ye, H Zhao, MK Tsai, ... Bmj 360, 2018 | 151 | 2018 |
| Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence EH Lin, M Hassan, Y Li, H Zhao, A Nooka, E Sorenson, K Xie, R Champlin, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 131 | 2007 |
| 8‐Hydroxy‐2′‐deoxyguanosine (8‐OH‐dG) as a potential survival biomarker in patients with nonsmall‐cell lung cancer J Shen, P Deininger, JD Hunt, H Zhao Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 124 | 2007 |
| Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer J Gu, H Zhao, CP Dinney, Y Zhu, D Leibovici, CE Bermejo, ... Clinical Cancer Research 11 (4), 1408-1415, 2005 | 120 | 2005 |
| An association between NQO1 genetic polymorphism and risk of bladder cancer SJ Park, H Zhao, MR Spitz, HB Grossman, X Wu Mutation Research/Genetic Toxicology and Environmental Mutagenesis 536 (1-2 …, 2003 | 114 | 2003 |
| Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study S Yao, G Zirpoli, DH Bovbjerg, L Jandorf, CC Hong, H Zhao, ... Breast Cancer Research 14, 1-13, 2012 | 107 | 2012 |
| Novel genetic variants in microRNA genes and familial breast cancer J Shen, CB Ambrosone, H Zhao International journal of cancer 124 (5), 1178-1182, 2009 | 103 | 2009 |
| The Consortium of Metabolomics Studies (COMETS): metabolomics in 47 prospective cohort studies B Yu, KA Zanetti, M Temprosa, D Albanes, N Appel, CB Barrera, ... American journal of epidemiology 188 (6), 991-1012, 2019 | 97 | 2019 |
| Circulating miR-148b and miR-133a as biomarkers for breast cancer detection J Shen, Q Hu, M Schrauder, L Yan, D Wang, L Medico, Y Guo, S Yao, ... Oncotarget 5 (14), 5284, 2014 | 92 | 2014 |
| Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a … C Tian, CB Ambrosone, KM Darcy, TC Krivak, DK Armstrong, ... Gynecologic oncology 124 (3), 575-581, 2012 | 92 | 2012 |
